Angiopoietin-2 — ein neuer Biomarker bei Patienten mit akuter Lungenembolie

Niemann, Caroline

dc.contributor.advisor	Lankeit, Mareike K. PD Dr.
dc.contributor.author	Niemann, Caroline
dc.date.accessioned	2016-11-28T07:09:41Z
dc.date.available	2016-12-15T23:50:06Z
dc.date.issued	2016-11-28
dc.identifier.uri	http://hdl.handle.net/11858/00-1735-0000-002B-7CBE-A
dc.identifier.uri	http://dx.doi.org/10.53846/goediss-5995
dc.language.iso	deu	de
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc	610	de
dc.title	Angiopoietin-2 — ein neuer Biomarker bei Patienten mit akuter Lungenembolie	de
dc.type	doctoralThesis	de
dc.title.translated	Angiopoietin-2 — a novel biomarker in patients with pulmonary embolism	de
dc.contributor.referee	Lankeit, Mareike K. PD Dr.
dc.date.examination	2016-12-08
dc.description.abstracteng	Angiopoietin-2 (Ang-2), an antagonist ligand of the endothelial-specific Tie2 receptor, inhibits the stabilizing influence of the Tie2 activator Ang-1, thereby promoting vascular remodeling. Elevated levels of Ang-2 are associated with impaired hemodynamic parameters and poor prognosis in patients with idiopathic pulmonary hypertension. This thesis aimed to investigate the prognostic value of Ang-2 in patients with acute pulmonary embolism (PE).	de
dc.contributor.coReferee	Patschan, Daniel Prof. Dr.
dc.subject.ger	Lungenembolie	de
dc.subject.ger	Angiopoietin-2	de
dc.subject.ger	CTEPH	de
dc.subject.eng	pulmonary embolism	de
dc.subject.eng	Angiopoietin-2	de
dc.subject.eng	CTEPH	de
dc.identifier.urn	urn:nbn:de:gbv:7-11858/00-1735-0000-002B-7CBE-A-4
dc.affiliation.institute	Medizinische Fakultät	de
dc.subject.gokfull	Kardiologie (PPN619875755)	de
dc.description.embargoed	2016-12-15
dc.identifier.ppn	87500265X

Dateien

Name:CN_DISS_SUB2.pdf

Größe:1.906Mb

Format:PDF

Beschreibung:Dissertation

Öffnen

Name:: CN_DISS_SUB2.pdf
Größe:: 1.906Mb
Format:: PDF
Beschreibung:: Dissertation

Öffnen

Das Dokument erscheint in:

Human- und Zahnmedizin [2872]

Zur Kurzanzeige